In future studies, we will investigate the regenerative and therapeutic potential of this newly designed auspicious TE mRNA variant for improving wound healing and preventing and restoring scar tissue, as well as for other diseases, such as myocardial infarction or aneurysms, that require de novo elastin synthesis. This evidence concerns the gene ELN and myocardial infarction.